自我檢驗:醫療設備開發平台評估(2020年)

自我檢驗設備，是個人能在家診斷健康的診斷設備，有助於使用患者樣本，監視病情。

本報告提供自我檢驗用醫療設備的開發中產品的相關調查，產品概要，許可證，合作，開發活動詳細內容，主要企業的檢討及計劃的清單，開發中產品的主要的臨床實驗資料等資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

• 各開發階段
• 各地區
• 各法規途徑
• 各估計核准日
• 持續性臨床試驗

第4章 企業開發中的開發中產品

• 自我檢驗企業:各開發階段的開發中產品
• 自我檢驗:各開發階段的開發中產品

第5章 企業與產品概要

• bioLytical Laboratories Inc
• Boston Microfluidics
• Brigham and Women's Hospital
• Emory University
• Entia Ltd
• InnaMed Inc
• Module Innovations Pvt Ltd
• Morgan Innovation And Technology Ltd
• Novosanis NV
• OncoGenesis
• Premier Medical Corporation
• Shanghai Kehua Bio-engineering Co Ltd
• Svenska Cellulosa Aktiebolaget
• Tasso, Inc.
• University of Washington
• Wellmetrix LLC

第6章 最近的開發

第7章 附錄

GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Self Testing pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Self Testing Devices are diagnostic devices enables an individual to diagnose health at home and helps to monitor disease condition using patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Self Testing Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Self Testing Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Self Testing Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

2 Introduction

3 Products under Development

• 3.1 Self Testing - Pipeline Products by Stage of Development
• 3.2 Self Testing - Pipeline Products by Territory
• 3.3 Self Testing - Pipeline Products by Regulatory Path
• 3.4 Self Testing - Pipeline Products by Estimated Approval Date
• 3.5 Self Testing - Ongoing Clinical Trials

4 Self Testing - Pipeline Products under Development by Companies

• 4.1 Self Testing Companies - Pipeline Products by Stage of Development
• 4.2 Self Testing - Pipeline Products by Stage of Development

5 Self Testing Companies and Product Overview

• 5.1 bioLytical Laboratories Inc Company Overview
• 5.2 Boston Microfluidics Company Overview
• 5.3 Brigham and Women's Hospital Company Overview
• 5.4 Emory University Company Overview
• 5.5 Entia Ltd Company Overview
• 5.6 InnaMed Inc Company Overview
• 5.7 Module Innovations Pvt Ltd Company Overview
• 5.8 Morgan Innovation And Technology Ltd Company Overview
• 5.9 Novosanis NV Company Overview
• 5.10 OncoGenesis Company Overview
• 5.11 Premier Medical Corporation Company Overview
• 5.12 Shanghai Kehua Bio-engineering Co Ltd Company Overview
• 5.13 Svenska Cellulosa Aktiebolaget Company Overview
• 5.14 Tasso, Inc. Company Overview
• 5.15 University of Washington Company Overview
• 5.16 Wellmetrix LLC Company Overview

6 Self Testing- Recent Developments

7 Appendix

List of Tables

• Table 1: Self Testing - Pipeline Products by Stage of Development
• Table 2: Self Testing - Pipeline Products by Territory
• Table 3: Self Testing - Pipeline Products by Regulatory Path
• Table 4: Self Testing - Pipeline Products by Estimated App

List of Figures

• Figure 1: Self Testing - Pipeline Products by Stage of Development
• Figure 2: Self Testing - Pipeline Products by Territory
• Figure 3: Self Testing - Pipeline Products by Regulatory Path
• Figure 4: Self Testing - Pipeline Products by Estimated Approval Date
• Figure 5: Self Testing - Ongoing Clinical Trials